METABOLIC DIVERSITY |
Extensive biological and chemical screening of our culture library allows us to create a whole range of specialised targeted collections. Any combination of bioactivities can be selected and matched to the desired physico-chemical attributes to address even the most stringent metabolite requirements - the potential is almost limitless:
As an illustration of the power of our databases, we can identify those cultures in our collection that produce potentially novel staurosporine analogues by two simple and rapid steps. First, a search of our physico-chemical database for the highly distinctive staurosporine UV chromophore; second, a search for cultures with the correct bioactivity profile. By combining these searches we identify 45 cultures for further investigation. Taking a lateral view, if we want novel but unrelated inhibitors with a staurosporine mode of action we look for actives with the staurosporine bioactivity profile but without the characteristic staurosporine UV chromophore.
![]() Microbial Screening's New Chemical Entity (NCE) libraries are for those clients looking for novel actives within existing therapeutic areas. NCE libraries offer a flying start with existing IP and novel actives, supported by a discovery pipeline from Day 1.
Microbial Screening' NCE libraries consist of 50 to 100 cultures with activity against a particular therapeutic target. They are derived from an initial primary screen of at least 20,000 cultures. Only those cultures producing selective and potent activity are considered; known actives are eliminated. Up to 25% of the cultures in an NCE library are advanced to fermentation to optimise production, of which half are scaled-up to provide sufficient material for completion of the isolation chemistry. A proportion of the scaled-up cultures has been progressed to preparative fractionation leading to the isolation and structure elucidation of pure metabolites. Implicit in the creation of a new NCE library are:
An NCE library provides not only a number of novel actives for immediate investigation, it also provides a pipeline for future discoveries.
![]() |

Home | Business Development | Micorbial Diversity | Metabolic diversity | Chemical Diversity | Bioassay Platforms
Dereplication | Fermentation | Publications | Bioaustralis | Contact Us | ©2003 MICROBIAL SCREENING TECHNOLOGIES